©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 115048
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.115048
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.115048
Figure 2 Pathophysiology of sarcopenia in cirrhosis.
Pathophysiological mechanisms linking cirrhosis to sarcopenia, including hyperammonemia, endotoxemia, cytokine release, and insulin resistance, all of which contribute to anabolic resistance, muscle mass loss, and functional decline. IL-6: Interleukin-6; TNF-α: Tumor necrosis factor-α.
- Citation: Goyal MK, Chowdhary R, Vohra C, Patel M, Kalra S, Mehta M, McNulty R, Goyal K, Vuthaluru AR, Goyal O. Current management strategies for sarcopenia and frailty in cirrhosis: Missing link in transplant candidacy. World J Hepatol 2026; 18(1): 115048
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/115048.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.115048